Connect with us

Health

For Children in Rural Mozambique, the Future Comes Into Focus

Published

on

For Children in Rural Mozambique, the Future Comes Into Focus

Over the past year, Muanema Fakira noticed something odd about the eyes of her 1-year-old daughter Sumaya. Her left eye was cloudy. It did not gleam with curiosity or glint in the sun. When the problem persisted, Ms. Fakira made the rounds to health clinics in their town in central Mozambique. Doctors said they could not help.

But they knew of someone who could, if Ms. Fakira could take Sumaya, now 2, on a 100-mile journey to the coast.

The family made the trip to the city of Quelimane, where Dr. Isaac Vasco da Gama examined Sumaya’s eyes and quickly diagnosed a congenital cataract.

Ms. Fakira was skeptical — cataracts are for old people, she said. But Dr. da Gama explained that an infection at birth, or shortly after, can cause cataracts in children. The condition is particularly worrying because vision problems affect the development of a child’s physical function. But the good news, he said, was that the problem can be solved with a simple surgery, one he does a dozen times a week at Quelimane Central Hospital.

This was particularly lucky for Sumaya because Dr. da Gama is one of just three pediatric ophthalmologists in Mozambique, a country of 30 million people.

Advertisement

Sumaya had her surgery in November, and a day later headed home, already recovering. Dr. da Gama was pleased to have seen her while she was still young, before permanent damage was done.

It was a sign that a system he and colleagues have been trying to put in place for the last few years might be taking hold: Sumaya’s parents sought help from the medical system for an eye problem — rather than a traditional healer, or a sorcerer to remove a curse.

When Sumaya was referred for care, it was a long and expensive trip, but she got help relatively quickly for a problem that might otherwise have blighted her life. Ideally her cataract would have been spotted at birth by a midwife.

“I do believe that by pushing forward, we can slowly overcome this challenge,” Dr. da Gama said.

In Mozambique, as in much of sub-Saharan Africa, awareness of vision problems is so low, and access to help so limited, that few children get the care they need, even though many suffer from easily treatable problems.

Advertisement

In 2021, a global commission on eye health reported that 510 million people around the world, 90 percent of them in low- and middle-income countries, had uncorrected vision impairment. That is, they could not see properly because they did not have glasses.

The consequences are enormous: Children with vision loss in these countries are significantly less likely to be in school. One study found that for those who do attend school, those with uncorrected vision problems learn half as much as their peers with normal vision.

Access to treatment is so limited because of a scarcity of trained staff and a failure to integrate vision care into health systems. Children are not screened for vision loss, and parents and teachers don’t understand the simple causes of eye trouble that can manifest in distraction, lack of physical coordination and behavior issues.

Mozambique has just 20 ophthalmologists, up from six two decades ago. Almost all of them are based in the capital, Maputo, in the south.

Dr. da Gama completed his studies in India in 2017 and set up a clinic in Quelimane, a seaport town halfway up Mozambique’s long Indian Ocean coastline. But to his surprise, he saw very few patients in the first year. He discovered that no one was being referred to him because health workers did not recognize treatable eye diseases. He started traveling to local clinics to tell medical workers about screening and solutions.

Advertisement

Then he teamed up with the charity Light for the World, which had sponsored him to complete specialized training in pediatric eye care in Tanzania. They designed an outreach program to show teachers, community health workers, traditional healers and local leaders how to spot vision problems and to refer children to the new ophthalmology ward at the Quelimane hospital.

Now, a couple of times a year, for up to a month at a time, he takes a mobile clinic to small communities to do surgeries on children with cataracts, glaucoma or strabismus (misaligned eyes).

Cataracts cause nearly half the preventable blindness in Mozambique’s children; they can be genetic, or the result of trauma (like a stick or a stone in the eye), or of an untreated eye infection.

On his outreach journeys, Dr. da Gama teaches other health care workers how to perform the simple surgeries, and how to spot the conditions. “Operating per se is not a problem: We can train in a week, two weeks, how to operate on a cataract,” he said. “But it is how to identify the children who need the operations.”

Mozambique’s Ministry of Health is trying to build awareness of vision problems and refractive errors, for which a pair of glasses is a life-altering intervention.

Advertisement

Glasses or simple surgeries that keep children in school can change the future for their families, and for the country as a whole. “If you have children less educated or with fewer skills,” he said, “the future of the economy is affected.”

In Quelimane, Dr. da Gama also sees cases of retinoblastoma, a cancer of the retina. When patients come early enough, he can save their lives, if not their eyes.

Camilo Rosario brought his daughter Grace, 3, to his clinic in November, from their home in a village 300 kilometers (about 185 miles) away. She had a tumor protruding from her eye that caused her excruciating pain. Mr. Rosario said she had begun to complain about her eye just weeks before. He shifted anxiously from foot to foot while Dr. da Gama explained that he would operate quickly to remove the tumor, but that he feared the disease was already in her brain.

Grace soon recovered from the first surgery, clinging to her father with a bulky bandage around her head. But as Dr. da Gama had feared, she had come to him too late; she died in early January.

Aminata Kaba was screened alongside her classmates in high school last year — and was surprised to learn that she was myopic. After she got glasses, school became significantly easier, she said, and her grades soon improved. Now, she said, she will continue on in school, and she hopes to be a lawyer.

Advertisement

Screening older children is easy; coaxing cooperation out of the small ones is a much greater challenge, Dr. da Gama said. They rarely look where he needs them to for eye exams. The eyedrops, the equipment, even his white coat, all can be frightening. He said he smiles and sings to distract, removing the coat when required.

“I like difficult things,” he said.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Health

What are GLP-3s? Meet the new generation of weight-loss drugs with three key ingredients

Published

on

What are GLP-3s? Meet the new generation of weight-loss drugs with three key ingredients

NEWYou can now listen to Fox News articles!

GLP-1 has become a popular buzzword in the weight-loss community — but now some are touting “GLP-3s,” claiming they are taking obesity medications to the next level.

GLP-1 (glucagon-like peptide-1) medications work by mimicking a naturally occurring hormone in the body that helps regulate blood sugar and appetite.

The informal term “GLP-3” refers to a new triple-agonist drug that targets three hormones: GLP-1, GIP (glucose-dependent insulinotropic polypeptide, another naturally occurring hormone released by the gut after eating) and glucagon receptors. The most advanced example is retatrutide by Eli Lilly, according to clinical trial outcomes.

OBESITY EXPERT REVEALS THE BEST WAY TO DECIDE IF GLP-1S ARE RIGHT FOR YOU

Advertisement

The New England Journal of Medicine published results from a 2023 phase 2 retatrutide trial for obesity, revealing “substantial reductions in body weight” after 48 weeks of treatment.

A 12 mg once-weekly injection led to a 24.2% weight reduction, and participants continued to drop pounds after the 48-week trial period.

GLP-1 (glucagon-like peptide-1) medications work by mimicking a naturally occurring hormone in the body that helps regulate blood sugar and appetite. (iStock)

Side effects were reportedly similar to GLP-1 medications, most commonly including gastrointestinal complications like nausea, vomiting and diarrhea. Heart rate increases were noted, depending on the dose.

How it’s different

Retatrutide mimics three natural hormones found in the body, compared to GLP-1s that simulate just one hormone, according to a report by GoodRx pharmacists.

Advertisement

GIP and GLP-1 hormones signal the pancreas to release insulin after eating, while slowing digestion to help initiate feelings of fullness.

NEW WEGOVY PILL OFFERS NEEDLE-FREE WEIGHT LOSS — BUT MAY NOT WORK FOR EVERYONE

These hormones target the area of the brain that regulates appetite and influences food cravings, the report noted.

The third hormone, glucagon, speeds up metabolism and helps the body break down fat cells for energy. That hormone also tells the liver to make new sugar, which is kept in check by GIP and GLP-1 activity, preventing blood sugar spikes.

Participants in the phase 3 trial saw an average weight loss of 71.8 pounds. (iStock)

Advertisement

“This added metabolism boost can add to and complement GIP’s and GLP-1’s actions. And that’s why it seems to provide significant weight loss,” the GoodRx website states. “If approved, retatrutide will be the first in a new class of medications.”

Eli Lilly announced results from its phase 3 trial TRIUMPH-4 in December, testing retatrutide’s effect on weight loss and other health conditions.

“We believe retatrutide could become an important option for patients with significant weight loss needs and certain complications.”

Participants with obesity and knee arthritis who took a 12-mg dose of retatrutide saw an average weight loss of 71.8 lbs (28.7%) at 68 weeks.

“For retatrutide, the findings from TRIUMPH-4 are encouraging, and with seven additional phase 3 readouts expected in 2026, we believe retatrutide could become an important option for patients with significant weight loss needs and certain complications, including knee osteoarthritis,” a Lilly spokesperson said in a statement to Fox News Digital. 

Advertisement

CLICK HERE FOR MORE HEALTH STORIES

The drug also reduced Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain scores by an average of 75.8%, marking “significant improvements” in comfort level and physical function.

More than one in eight patients reported being “completely free” from knee pain at the end of the trial, according to a press release from Lilly.

Participants with obesity and knee arthritis who took a 12-mg dose of retatrutide saw an average weight loss of 71.8 lbs (28.7%) at 68 weeks. (iStock)

Seven additional phase 3 trials for retatrutide are expected to wrap up in 2026. The drug could see FDA approval in 2027, according to GoodRx.

Advertisement

The Lilly spokesperson noted that there have been no studies comparing retatrutide to GLP-1 treatments due to “differences in study design and patient populations.”

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Despite limited data availability on the drug, the medication could also be applied to treat other conditions like type 2 diabetes, kidney disease, cardiovascular risk reduction and metabolic dysfunction, according to GoodRx and other experts.

Fox News senior medical analyst Dr. Marc Siegel noted that Lilly’s Zepbound and Mounjaro already target two metabolic pathways — GLP-1 and GIP — which work together to promote weight loss, reduce hunger and inflammation, improve insulin function and slow digestion.

The doctor confirmed that the new drug, with its third receptor agonist, will further decrease hunger while increasing the feeling of fullness.

Advertisement

More than one in eight patients reported being “completely free” from knee pain at the end of the trial. (iStock)

“The weight loss in clinical trials is even more substantial, and the most likely reason that it decreases orthopedic problems is because of the weight loss — less stress on the joints and the decreased inflammation,” Siegel added.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The most common side effect of GLP-3s is gastrointestinal symptoms, the doctor confirmed. Rarer side effects may include pancreatitis, gallstones and heart arrhythmia.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Advertisement

Philip Rabito, M.D., a specialist in endocrinology, weight loss and wellness in New York City, shared in an interview with Fox News Digital that this new class of weight-loss drugs is positioned to “approach bariatric surgery level outcomes” — although it doesn’t come without risks.

“The novel glucagon‑agonist component introduces less‑understood long‑term safety considerations, so it is imperative that patients are followed closely by healthcare professionals experienced with this class of medicines, with cautious, stepwise use, despite the impressive efficacy,” he cautioned.

Advertisement
Continue Reading

Health

How much red meat is too much? Experts weigh in on food pyramid updates

Published

on

How much red meat is too much? Experts weigh in on food pyramid updates

NEWYou can now listen to Fox News articles!

The release of an updated food pyramid this week has sparked mixed reactions from doctors and dietitians.

One of the most noteworthy shifts in the 2025-2030 Dietary Guidelines for Americans — announced by HHS officials during a Jan. 7 press conference at the White House — is a greater emphasis on “high-quality proteins,” including red meat and eggs, as well as full-fat dairy.

The new guidelines focus on “real, whole, nutrient-dense foods,” and a dramatic reduction in highly processed foods, added sugars, refined carbohydrates and unhealthy fats.

HEALTH EXPERTS REACT AS ANDREW HUBERMAN BACKS TRUMP ADMIN’S NEW FOOD PYRAMID

Advertisement

“Protein and healthy fats are essential and were wrongly discouraged in prior dietary guidelines,” Health Secretary Robert F. Kennedy Jr. said during the press conference. “We are ending the war on saturated fats.”

Nick Norwitz, a Harvard- and Oxford-trained researcher known for his work in metabolic health, shared his reaction to the new guidelines.

The release of an updated food pyramid this week has sparked mixed reactions from doctors and dietitians. (realfood.gov)

Despite how the new pyramid is presented, he noted, the actual guidelines for saturated fat consumption haven’t changed, as they still state that, “in general, saturated fat consumption should not exceed 10% of total daily calories.”

The intake of unprocessed whole foods rich in saturated fat, especially dairy fat, tends to be associated with improved health outcomes, according to Norwitz.

Advertisement

RED MEAT CAN HELP YOUR MOOD IF PART OF A HEALTHY, BALANCED DIET, STUDY SUGGESTS

“Full-fat dairy — especially cheese, for example — tends to be associated with lower BMI, reduced rates of diabetes and even reduced dementia risk,” he told Fox News Digital. “There are, of course, nuances — but ‘ending the war’ on saturated fat seems reasonable.”

Risks vary, experts say

Experts cautioned about the potential health risks of exceeding the recommended intake of saturated fat, including higher rates of LDL “bad” cholesterol, which is known to increase the risk of cardiovascular disease.

“The recommendation to limit saturated fat to 10% of total calories is based on the research showing that higher rates increase LDL cholesterol and associated risks for cardiovascular disease,” Sherry Coleman Collins, a food allergy dietitian and expert from the Atlanta metropolitan area, told Fox News Digital. 

One of the most noteworthy shifts in the 2025-2030 Dietary Guidelines for Americans is a greater emphasis on “high-quality proteins” — including red meat and eggs — as well as full-fat dairy. (iStock)

Advertisement

Nutrition should be personalized and is dependent on multiple factors, she said, including age, gender, activity level and genetic risk factors.

“The total saturated fat an individual might safely consume is influenced by their size and total calorie needs, as well as potentially genetic differences,” Coleman Collins said.

Norwitz agreed, adding that “the specific food source and interaction with the unique host and their broader dietary context should take the spotlight.”

Dr. Pooja Gidwani, a double board-certified doctor of internal medicine and obesity medicine in Los Angeles, pointed out that not everyone has the same “tolerance” for saturated fats.

“If increasing saturated fat leads to a meaningful rise in LDL cholesterol or ApoB (Apolipoprotein B, a protein found on the surface of certain cholesterol-carrying particles in the blood), that intake level is excessive for that individual, regardless of improvements in weight or glucose metrics,” she said.

Advertisement

TRUMP ADMIN’S NEW NUTRITION GUIDELINES TARGET ULTRA-PROCESSED FOODS, EASE UP ON RED MEAT AND SATURATED FATS

“This personalized approach becomes increasingly important in midlife and beyond, when cardiovascular disease becomes the dominant driver of morbidity and mortality and when tolerance for cumulative atherogenic (artery-clogging) exposure is lower.”

For those who need to reduce LDL cholesterol or have a higher cardiovascular risk, the American Heart Association recommends an even lower amount of saturated fats — less than 6% of total daily calories.

Experts cautioned about the potential health risks of exceeding the recommended intake of saturated fat, including higher rates of LDL “bad” cholesterol. (iStock)

Gidwani also cautioned that diets emphasizing saturated fat could crowd out fiber and unsaturated fats, “both of which play independent roles in cholesterol clearance, insulin sensitivity, gut health and inflammation.”

Advertisement

“Saturated fat-heavy patterns are also calorie-dense, which can quietly undermine long-term weight management if intake is not carefully regulated,” she added.

Not all saturated fats are equal, experts say

The effects of saturated fat depend on what specific foods are being consumed, according to experts.

“I would recommend choosing minimally processed or unprocessed forms of foods,” said Tanya Freirich, a registered dietitian nutritionist in Charlotte, North Carolina. “For example, in place of a hot dog — which has additives, nitrites, sodium and fillers — consuming a chicken thigh would be a much better choice.”

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Gidwani reiterated that the amount of processing plays a big role.

Advertisement

“Processed meats are consistently associated with worse cardiometabolic outcomes and represent the clearest category to limit,” she said. “The risk here is not only saturated fat, but also sodium load, preservatives and the broader dietary pattern they tend to accompany.”

“Full-fat dairy — especially cheese, for example — tends to be associated with lower BMI, reduced rates of diabetes and even reduced dementia risk,” an expert told Fox News Digital. (iStock)

Unprocessed red meat, the doctor said, can fit into an overall healthy diet in smaller amounts, particularly when consumed alongside fiber-rich plants and minimally processed foods.

“However, from a longevity perspective, it should be viewed as optional rather than foundational, especially for individuals with elevated cardiovascular risk,” she added.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Advertisement

When it comes to dairy, Gidwani noted that fermented options are “metabolically more favorable” than butter or cream.

“However, saturated fat from dairy is still not necessary to prioritize for metabolic health or longevity,” she said. “Excessive reliance on dairy fat can displace healthier fat sources without offering clear long-term benefit.”

CLICK HERE FOR MORE HEALTH STORIES

Overall, the doctor recommends unsaturated fat sources, including extra virgin olive oil, nuts, seeds, avocado and omega-3-rich fish, as primary dietary fats.

“These consistently support lipid profiles, insulin sensitivity and vascular health,” Gidwani said. “Saturated fat can exist within a balanced diet, but it should remain secondary rather than emphasized.”

Advertisement

Why the big picture matters

Saturated fat is just one piece of a much wider nutrition puzzle, the experts agreed.

Unprocessed red meat can fit into an overall healthy diet in smaller amounts, particularly when consumed alongside fiber-rich plants and minimally processed foods, one expert said. (iStock)

“Our heart health is not determined by one type of fat or one type of cholesterol, but the sum of many parts — our entire diet, our exercise habits, our stress and so much more,” Freirich said.

She recommends consulting a registered dietitian for guidance on unique dietary needs based on age, gender, activity level and medical history.

“Our heart health is not determined by one type of fat or one type of cholesterol, but the sum of many parts — our entire diet, our exercise habits, our stress and so much more,” said an expert.  (iStock)

Advertisement

New Jersey-based dietitian Erin Palinski-Wade, author of “2-Day Diabetes Diet,” added that the message should be to focus more on overall patterns.

That means “plenty of fiber-rich plants, lean protein at every meal (including those that also contain fiber, such as nuts and seeds) and a reduction in overall intake of added sugars.”

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

“That change will drive true health improvements,” she said.

Advertisement
Continue Reading

Health

The Wegovy Pill Is Here: See the Cost and How Much Weight You Can Lose

Published

on

The Wegovy Pill Is Here: See the Cost and How Much Weight You Can Lose


Advertisement


No Shots Required! Doctors Say the New $25 a Month Wegovy Pill Works | Woman’s World




















Advertisement











Advertisement




Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Trending